Created in 2014 (United States), EACT own 32 sister brands and 17477 competing brands. EACT is a brand of Gilead Sciences, listed on the stock exchange of New York. EACT belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Gilead Sciences
(EACT)
over 5 years*
USD 70.08